Source: Korea Biomedical Review

AstraZeneca: KHIDI and AstraZeneca support Korean biopharma' expansion into China

The Korea Health Industry Development Institute (KHIDI) and AstraZeneca Korea have jointly supported the entry of leading Korean pharmaceutical and biotechnology companies into the Chinese market through the "K-Bio Expressway Project," which took place from April 22 to 26.The project stems from a me

Read full article »
Annual Revenue
$50-100B
Employees
50-100K
Pascal Soriot's photo - CEO of AstraZeneca

CEO

Pascal Soriot

CEO Approval Rating

72/100

Read more